5-hydroxytryptophan has been researched along with fluorodeoxyglucose f18 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bombardieri, E; Chiti, A; De Deckere, E; Maccauro, M; Savelli, G | 1 |
| Brouwers, AH; de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; Vanghillewe, K | 1 |
| Karges, W; Mottaghy, FM; Van Binnebeek, S | 1 |
| Chevallier, P; Legmann, P; Prat, F; Taieb, D; Tenenbaum, F | 1 |
| Giovanella, L; July, M; Santhanam, P; Treglia, G | 1 |
2 review(s) available for 5-hydroxytryptophan and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Nuclear medicine imaging of neuroendocrine tumours.
Topics: 3-Iodobenzylguanidine; 5-Hydroxytryptophan; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed | 2001 |
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Methionine; Multiple Endocrine Neoplasia; Mutation; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin | 2018 |
3 other study(ies) available for 5-hydroxytryptophan and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Adult; Aged; Carbon Radioisotopes; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Functional imaging of neuroendocrine tumors.
Topics: 5-Hydroxytryptophan; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Ephedrine; Etomidate; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Peptides; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Somatostatin | 2011 |
Topographic diagnosis: respective roles of morphological and functional imaging.
Topics: 5-Hydroxytryptophan; Anatomy, Cross-Sectional; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemia; Imaging, Three-Dimensional; Insulinoma; Magnetic Resonance Imaging; Pancreatic Neoplasms; Practice Guidelines as Topic; Receptors, Glucagon; Receptors, Somatostatin | 2013 |